CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited) - USD ($)	Total	Common Stock Class A	Common Stock Class B	Additional Paid-In Capital	Accumulated Deficit	Accumulated other comprehensive Income (loss)
Balance, shares at Dec. 31, 2020		117,000,000
Balance, amount at Dec. 31, 2020	$ 1,167,619	$ 117,000	$ 0	$ 1,991,617	$ (942,994)	$ 1,996
Capital contributions to Yubo Beijing	127,164	$ 0	$ 0	127,164	0	0
Reverse acquisition of Yubo International Biotech Limited by Platinum International Biotech Co. Ltd., shares		1,177,885	4,447
Reverse acquisition of Yubo International Biotech Limited by Platinum International Biotech Co. Ltd., amount	0	$ 1,178	$ 4	(1,182)	0	0
Net loss	(438,676)	0	0	0	(438,676)	0
Foreign currency translation adjustment	70,413	$ 0	$ 0	0	0	70,413
Balance, shares at Mar. 31, 2021		118,177,885	4,447
Balance, amount at Mar. 31, 2021	926,520	$ 118,178	$ 4	2,117,599	(1,381,670)	72,409
Balance, shares at Dec. 31, 2020		117,000,000
Balance, amount at Dec. 31, 2020	1,167,619	$ 117,000	$ 0	1,991,617	(942,994)	1,996
Net loss	(1,145,267)
Foreign currency translation adjustment	72,789
Balance, shares at Sep. 30, 2021		118,177,885	4,447
Balance, amount at Sep. 30, 2021	222,304	$ 118,178	$ 4	2,117,599	(2,088,262)	74,785
Balance, shares at Mar. 31, 2021		118,177,885	4,447
Balance, amount at Mar. 31, 2021	926,520	$ 118,178	$ 4	2,117,599	(1,381,670)	72,409
Net loss	(370,008)	0	0	0	(370,008)	0
Foreign currency translation adjustment	13,122	$ 0	$ 0	0	0	13,122
Balance, shares at Jun. 30, 2021		118,177,885	4,447
Balance, amount at Jun. 30, 2021	569,634	$ 118,178	$ 4	2,117,599	(1,751,678)	85,531
Net loss	(336,584)	0	0	0	(336,584)	0
Foreign currency translation adjustment	(10,746)	$ 0	$ 0	0	0	(10,746)
Balance, shares at Sep. 30, 2021		118,177,885	4,447
Balance, amount at Sep. 30, 2021	222,304	$ 118,178	$ 4	2,117,599	(2,088,262)	74,785
Balance, shares at Dec. 31, 2021		118,177,885	4,447
Balance, amount at Dec. 31, 2021	(131,198)	$ 118,178	$ 4	2,117,599	(2,485,432)	118,453
Net loss	(578,948)	0	0	0	(578,948)	0
Foreign currency adjustment	(49,977)	$ 0	$ 0	0	0	(49,977)
Balance, shares at Mar. 31, 2022		118,177,885	4,447
Balance, amount at Mar. 31, 2022	(760,123)	$ 118,178	$ 4	2,117,599	(3,064,380)	68,476
Balance, shares at Dec. 31, 2021		118,177,885	4,447
Balance, amount at Dec. 31, 2021	(131,198)	$ 118,178	$ 4	2,117,599	(2,485,432)	118,453
Net loss	(1,308,603)
Foreign currency translation adjustment	(37,559)
Balance, shares at Sep. 30, 2022		119,816,343	4,447
Balance, amount at Sep. 30, 2022	(658,141)	$ 119,816	$ 4	2,935,190	(3,794,035)	80,884
Balance, shares at Mar. 31, 2022		118,177,885	4,447
Balance, amount at Mar. 31, 2022	(760,123)	$ 118,178	$ 4	2,117,599	(3,064,380)	68,476
Net loss	(491,559)	0	0	0	(491,559)	0
Foreign currency adjustment	50	$ 0	$ 0	0	0	50
Balance, shares at Jun. 30, 2022		118,177,885	4,447
Balance, amount at Jun. 30, 2022	(1,251,632)	$ 118,178	$ 4	2,117,599	(3,555,939)	68,526
Net loss	(238,096)	$ 0	0	0	(238,096)	0
Foreign currency translation adjustment	12,368
Conversion of World Precision debt, shares		1,638,458
Conversion of World Precision debt, amount	819,229	$ 1,638	0	817,591	0	0
Foreign currency adjustments	12,368	$ 0	$ 0	0	0	12,368
Balance, shares at Sep. 30, 2022		119,816,343	4,447
Balance, amount at Sep. 30, 2022	$ (658,141)	$ 119,816	$ 4	$ 2,935,190	$ (3,794,035)	$ 80,884